INTRODUCTION
Perinatal hypoxicischemic encephalopathy (HIE) is a common cause of neonatal morbid ity and mortality and neurological disabilities among survivors [1] . Each year 1.2 million neo nates die and about one million infants have permanent neurological disability caused by perinatal HIE [2] . The pathogenesis of perina tal hypoxicischemic brain damage is highly complex, and involves impaired bloodbrain barrier permeability, energy failure, loss of cell ion homeostasis, acidosis, increased intracellu lar calcium, excitotoxicity, free radical mediated toxicity, growth factor deficiency or upregula tion and activation inflammatory cascade in immature brain [3] . Free radicals are highly reactive molecules generated predominantly during cellular respiration and normal metabo lism. Imbalance between cellular production of free radicals and the ability of cells to defend against them is referred to as oxidative stress. Glutathione peroxidase (GPX) is a principal antioxidant enzyme and protects the cells against intracellular radicals and peroxides coming from the respiratory chain or other metabolic pathways. A number of studies docu mented that HIE were associated with increased production of free radicals in animal models [4] . The direct measurement of free radicals in biological samples is difficult because they are extremely reactive and have a short half life. Therefore, particularly in human studies, indirect approaches have been used to demon strate free radical production during cerebral hypoxiaischemia, measuring the products of free radical reaction with other molecules, such as lipids, proteins, and DNA, and the level or activity of antioxidant molecules. Neuron spe cific enolase (NSE) was originally described by Moore and McGregor [5] in 1965. NSE is intracytoplasmic glycolytic enzyme in neurons. Enolase has five isoenzymes. Those containing the gamma subunit, predominantly found in neurons of the central and peripheral nervous system are called NSE [6] . The major distinctive feature of NSE compared with other enolases is its high degree of stability.
OBjECTIvE
In this study, we assessed the role of oxida tive stress in perinatal hypoxicischemic brain injury. We estimated perinatal oxidative brain damage measuring activity of GPX in cerebro spinal fluid (CSF) as the indirect biomarker of free radical production during cerebral hypoxia ischemia in correlation with level of intracel lular enzyme NSE in CSF as a good biomarker of the extend of brain injury. Understanding the mechanisms of perinatal hypoxicischemic brain injury is essential to the design of effective neuroprotective interventions.
SUMMARy Introduction
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METHODS

Our
Complete obstetrical history and physical examina tions were obtained on admission. Perinatal HIE was cat egorized into three stages according to Sarnat and Sarnat clinical scoring system and changes seen on amplitude integrated EEG. Amplitudeintegrated electroencepha lography (aEEG) was recorded during the first three days of life using cerebral function monitorCFM Olympic 6000 (Olympic Biomedical, USA). Mild HIE (HIE stage I) was defined as an altered level of consciousness that included irritability with periods of spontaneous eye opening and jit teriness, slightly abnormal muscle tone, exaggerated Moro and absence of autonomic dysfunction and with normal continuous aEEG patterns (upper margin of the trace >10 μV and lower margin >5 μV) and without seizures. Moderate HIE (HIE stage II) was defined as somnolence with hypotonia, weak primitive reflexes, constricted pupils, bradycardia or periodic breathing and moderately abnor mal aEEG patterns (upper margin of the trace >10 μV and the lower margin <5 μV) and with early seizures. Severe HIE (HIE stage III) was defined as stupor or coma with decerebrate posture, absent spontaneous activity, flaccid hypotonia, absent reflexes, seizures, nonreactive pupils and brainstem dysfunction with abnormal cranial nerve function and severely abnormal aEEG patterns (upper margin of the trace <10 μV and the lower margin <5 μV). A severely abnormal aEEG patterns may be accompanied by burst suppression or seizure activity.
Head sonograms were performed on all neonates before enrolment. Lumbar puncture was indicated for neonates as a part of the diagnostic workup for suspected perinatal HIE to rule out other intracranial disorders (e.g., congeni tal or acquired neonatal infections, neonatal meningitis, inborn errors of metabolism) that may mimic the clinical features of perinatal HIE. Lumbar puncture for GPX analy ses and NSE analyses were done in the first 72 hours of life. All samples were immediately frozen and stored at 80°C until analysed. Hemorrhagic traumatic CSF samples were discarded. GPX activity in CSF was measured indirectly by a coupled reaction with glutathione reductase (GR) as determined by a modified method originally performed by Paglia and Valentine. The GPX activity was measured spectrophotometrically by GR recycling method, using an available commercial assay kit, according to the manufac turer's instructions (Ransel test kit, Randox Laboratories Ltd, UK). Concentrations of NSE in CSF were measured using commercial NSE kit according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany).
Neurodevelopment outcome was assessed at 12 months of corrected gestational age by the neonatologist and the paediatric neurologist using the Denver Developmental Screening Test (DDST). Neurodevelopment outcome was classified as normal outcome, mild motor develop ment delayed (slight abnormality in muscular tone or mild delayed of motor development) and severe adverse outcome (cerebral palsy, epilepsy or if died in follow up period).
We excluded infants with congenital malformations, inherited metabolic disorders, congenital or acquired neo natal infections and maternal drug addiction.
All statistical analyses were performed using SPSS for Windows (Chicago, IL, USA Receiver operating curve (ROC) was used to determine a cutoff point for the prediction of abnormal neurodevelop ment outcomes. Sensitivity, specificity and accuracy were then calculated.
RESULTS
We studied 90 neonates (gestational age >32 weeks) with perinatal asphyxia who subsequently developed HIE. Fiftyseven neonates had mild HIE, 24 moderate HIE, and 9 severe HIE. Birth weight (BW) and gestational age (GA) were similar among the neonates with mild, mod erate or severe HIE, while male and female proportions varied between different HIE groups (p<0.05) ( (cerebral palsy, epilepsy or died in follow up period). Two preterm neonates with severe HIE died, one within early neonatal period because of multiorgan failure, the other died later because of respiratory dysfunction. Incidences of neurological sequels were significantly higher in pre term infants (p<0.05). NSE exhibited superior prediction of abnormal outcomes at 12 months of age (sensitivity was found 100% and specificity 81%) when compared to GPX activity in CSF (sensitivity was 87% and specificity 69%) (Graph 5).
DISCUSSION
Perinatal hypoxicischemic brain damage is a major cause of acute mortality and chronic neurological morbidity in infants and children [8] . The incidence of perinatal HIE varies at different gestational ages. Statistics suggest an incidence of HIE 35 per 1000 fullterm births and an inci dence approaching 60% in premature newborns [9] . In our study, the incidence of perinatal HIE was similar. The agedependent regional vulnerability to hypoxicischemic insults seen in the immature brain can be explained, at least in part, by the density of NMDA receptors and nNOS positive cells. The immature brain is especially sensitive to oxidative damage in comparison to the mature brain, because it has poor antioxidant capabilities and a high con centration of free iron and lipids. In our study males had a higher incidence of long term developmental disabilities than females. A recent analysis of a European database of 4500 children with cerebral palsy found that the inci dence of CP was 30% higher in males. Sex differences in the immature brain appear to be strongly influenced by intrin sic differences between male and female cells and that this is influenced by the sex chromosomes and sex hormones [10] . The incidence of longterm complications depends on the severity of HIE. Understanding of the mechanisms of perinatal hypoxicischemic brain injury is essential to the design of effective neuroprotective interventions [11, 12] . Treatment is currently limited to supportive intensive care, but efforts have been made to develop more effective thera pies. In adults, neuronal necrosis and apoptosis after global ischemia are slow, and last for several hours to several days. Studies in animals suggest a quicker cellular destruction and energy substrates in the neonatal brain continue to run down for 12 to 48 h after perinatal hypoxia [13] . Therefore, a neuroprotective intervention might be effective from 6 to 8 hours after perinatal asphyxia. As neuroprotective interventions may be harmful, it is important to find early and reliable indicators of brain damage or poor longterm prognosis to initiate neuroprotective treatment [14] . The information obtained by examination of CSF is often of crucial importance in the diagnosis of many neurological diseases (HIE, ischemic stroke and different types of meningitis). Several studies measured different biochemical factors in serum and CSF after the hypoxic ischemic events [15, 16] . After irreversible cellular injury, brain cells die by necrotic lysis or apoptosis, which releases intracellular enzyme such as NSE. A high level NSE in CSF is considered as the result of neural damage and it could be a good biomarker of brain damage or dysfunction of CNS [17, 18] . The optimal time for measuring released intracellular enzyme in CSF remains uncertain. In studies of adults, NSE increased 18 hours to four days after cerebral infarction and during the first days following anoxaemia [19] . As delayed neuronal death peaks between the 2 nd and 3 rd day of life, the optimal time is most likely to be at around 72 hours. Our results provide a strong association between concentrations of NSE in CSF and severity of stage of HIE, extent of brain damage and subsequent neurologi cal outcome. CSF contains both powerful enzymatic and nonenzymatic antioxidants, and CSF analysis provides some important clues about the physiological or pathologi cal changes in the central nervous system. There is little information in the literature on the evaluation of oxidative stress markers in CSF. Our present results showed that the activity of GPX in CSF was markedly higher in the preterm neonates and neonates with severe HIE. Increased GPX activity in CSF occurred in response to hypoxicischemia and might suggest the overproduction of reactive oxygen species and brain oxidative stress. In agreement with our results, a gradual increase of GPX activity in CSF have indicated advancing stage of HIE and the extent of brain damage. Free radicals, which are produced continuously during oxidative metabolism, are generated at high rates within the brain. Oxidative stresses due to overproduc tion of free radicals effectively overwhelms the reduced antioxidative mechanisms of the newborn and have been suggested as possible factors contributing to the patho genesis of perinatal hypoxicischemic brain injury [20] . The brain contains lower superoxide dismutase, catalase and GPX activity compared with kidney or liver [21] . The neonatal brain is particularly vulnerable to oxidative dam age because of its high concentration of lipids, high rate of oxygen consumption, decreased levels of antioxidant enzymes (i.e. GPX and catalase) and increased availability of free iron [22, 23] . Oxidative injury takes place mostly during the reperfusion phase [24] . Free radicals can lead to lipid peroxidation as well as DNA and protein damage and can trigger apoptosis [25, 26] . Finally, free radicals can combine with nitric oxide to form peroxynitrite, a highly toxic oxidant. Free radicals also induce inflammation and further formation of more oxidative radicals during the reperfusion phase via nonprotein bound and prooxidant enzymes, such as nitric oxide synthase, cyclooxygenase/ lipooxygenase, and xanthine oxidase [27] . The increased free radicals level causes destruction of the endothelial monolayer tight junctions of bloodbrain barrier (BBB) and increases its permeability [28] . Disruption of BBB results in increased vascular permeability, brain oedema, and secondary brain damage [29] . Data associated with GPX activity after acute hypoxicischemic brain injury is controversial. The GPX activity in patients with acute hypoxicischemic insult was reported to be decreased, increased or unchanged in both CSF and serum. In our study, we noted increased GPX activity in CSF in neonates with advanced stage of HIE and lower gestation age which is in accordance with published data, however, we observed a significant correlation between the severity of stage of HIE and GPX activity in CSF. Increased GPX activity of CSF in neonates with HIE might be an indicator of perina tal hypoxicischemic brain injury and improve our ability to optimize the timing and assessment of neuroprotective treatment at the same time.
CONCLUSION
The results of our study may have clinical and research implications. We postulate that oxidative stress might be an important contributing factor in the pathogenesis of perinatal hypoxicischemic brain injury particularly in preterm neonates. Our results demonstrate that increased GPX activity in CSF is related to the extent of brain injury and subsequent neurological abnormalities in infants with perinatal HIE, which might be prevented by antioxidative treatment. Further experimental and clinical studies are needed to clarify this point.
